Peptides and their use in the treatment of skin
View Patent ↗Embodiments of the invention are related generally to the methods of diminishing the signs of aging in and/or improving health of human integuments, such as skin, and compositions comprising peptides useful therefor. The compositions according to the invention may comprise one or more peptides or fragments or derivatives thereof derived from a growth factor, e.g., Growth Differentiation Factor 11 (GDF11), in a topically acceptable vehicle.
1. A method for diminishing the appearance of dermatological signs of aging comprising topically applying to the skin a composition comprising, in a topically acceptable vehicle, a peptide consisting of from 3 to 12 amino acids corresponding to a sequence of GDF11, or a salt, ester, or prodrug thereof, wherein said peptide increases collagen production in skin and/or increases hyaluronic acid production in skin,
wherein said sequence of GDF11 comprises MVV.
2. The method according to claim 1 , wherein said dermatological signs of aging include the appearance of fine lines and wrinkles.
3. The method according to claim 1 , wherein said peptide increases collagen production in skin.
4. The method according to claim 1 , wherein said peptide increases hyaluronic acid production in skin.
5. The method according to claim 1 , wherein said composition is applied at least once daily for at least one week.
6. The method according to claim 1 , wherein said skin is human skin.
7. The method according to claim 1 , wherein said peptide consists of from 3 to 8 amino acids corresponding to a sequence of GDF11.
8. The method according to claim 1 , wherein said peptide consists of from 3 to 6 amino acids corresponding to a sequence of GDF11.
9. The method according to claim 1 , wherein said peptide consists of MVV.
10. The method according to claim 1 , wherein said peptide consists of three or four consecutive amino acids corresponding to a sequence of GDF11.
11. The method according to claim 1 , wherein said peptide further comprises a hydrocarbon chain on the amino terminus.
12. The method according to claim 11 , wherein said hydrocarbon chain is a C 1-24 aliphatic hydrocarbon.
13. The method according to claim 12 , wherein said composition comprises a prodrug of said peptide, wherein said prodrug includes N-acetyl derivatives of said peptide.